Search results
Results from the WOW.Com Content Network
In May 2019, Tonix reported in-licensing the Phase 2 asset, TNX-1300 (T172R/G173Q double-mutant cocaine esterase 200 mg, i.v. solution), for the treatment of cocaine intoxication. [58] [59] TNX-1300 (formerly known as RBP-8000) is being developed under an Investigational New Drug application (IND) for the treatment of cocaine intoxication. [60]
As of Monday (the latest available data), 53% of 34 S&P 500 companies (comprising 10% of index earnings) that have reported so far beat on both sales and earnings per share, Bank of America’s ...
Tianeptine/naloxone (developmental code names TNX-601, TNX-601-CR, TNX-601-ER), or naloxone/tianeptine, is an extended-release combination of tianeptine, an atypical μ-opioid receptor agonist, and naloxone, an orally inactive μ-opioid receptor antagonist, which was under development for the treatment of major depressive disorder, post-traumatic stress disorder (PTSD), and neurocognitive ...
Stock market today: Indexes jump to kick off 2025 as market aims to snap 4-day losing streak ... which implies a potential gain of about 11% from the index's current levels. Initial jobless claims ...
The Levkovich Index, which takes into account investors' short positions and leverage, among other factors, to determine market sentiment, currently sits at a reading of 0.62, above the euphoria ...
Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL
Indexes closed lower in the first trading day of the year on Thursday. The losses extend the market's losing streak to five days, putting the Santa Claus rally at risk. Apple stock dropped more ...
The CBOE Volatility Index, or VIX, jumped above 34, or well above its longer-run average of around 20. "The path of least resistance remains lower for global equity markets to start the week.